STRATA CRITICAL MEDICAL INC (SRTA) Forecast, Price Target & Analyst Ratings

NASDAQ:SRTAUS0926671043

Current stock price

5 USD
+0.21 (+4.38%)
At close:
4.94 USD
-0.06 (-1.2%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for STRATA CRITICAL MEDICAL INC (SRTA).

Forecast Snapshot

Consensus Price Target

Price Target
$8.99
+ 79.77% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.04
Revenue Estimate
64.949M

ChartMill Buy Consensus

Rating
84.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.99
Upside
+ 79.77%
From current price of $5.00 to mean target of $8.99, Based on 10 analyst forecasts
Low
$8.08
Median
$8.16
High
$11.81

Price Target Revisions

1 Month
-8.44%
3 Months
-8.44%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for SRTA. The average price target is 8.99 USD. This implies a price increase of 79.77% is expected in the next year compared to the current price of 5.
The average price target has been revised downward by 8.44% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

SRTA Current Analyst RatingSRTA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

SRTA Historical Analyst RatingsSRTA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.00%
SRTA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SRTA.
In the previous month the buy percentage consensus was at a similar level.
SRTA was analyzed by 10 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-25B. Riley SecuritiesInitiate Buy
2026-03-25Craig-HallumInitiate Buy
2025-09-17Lake StreetMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.04
Revenue Estimate
64.949M
Revenue Q2Q
19.60%
EPS Q2Q
10.75%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
-0.58%
Revenue (3 Months)
1.56%
EPS (1 Month)
-16.67%
EPS (3 Months)
30.00%

Next Earnings Summary

SRTA is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.04 USD and the consensus revenue estimate is 64.95M USD.
The next earnings revenue estimate has been revised upward by 1.56% in the past 3 months.

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
SRTA revenue by date.SRTA revenue by date.
225.18M
54.13%
248.693M
10.44%
197.141M
-20.73%
274.56M
39.27%
299.52M
9.09%
EBITDA
YoY % growth
SRTA ebitda by date.SRTA ebitda by date.
-40.253M
10.09%
-22.205M
44.84%
-14.168M
36.19%
30.702M
316.70%
36.669M
19.44%
EBIT
YoY % growth
SRTA ebit by date.SRTA ebit by date.
-47.364M
6.21%
-28.167M
40.53%
-22.353M
20.64%
-12.138M
45.70%
-6.834M
43.70%
Operating Margin
SRTA operating margin by date.SRTA operating margin by date.
-21.03%-11.33%-11.34%-4.42%-2.28%
EPS
YoY % growth
SRTA eps by date.SRTA eps by date.
-0.76
-78.82%
-0.37
51.32%
-0.26
29.73%
-0.10
60.77%
-0.01
90.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.04
10.75%
-0.03
43.90%
-0.02
54.10%
-0.02
85.13%
-0.01
71.43%
0.00
100.00%
0.00
100.00%
0.01
157.14%
Revenue
Q2Q % growth
64.949M
19.60%
67.486M
-4.68%
69.551M
41.08%
72.548M
8.63%
72.012M
10.87%
74.358M
10.18%
74.97M
7.79%
78.234M
7.84%
EBITDA
Q2Q % growth
6.483M
210.26%
7.338M
595.48%
7.937M
1,883.60%
8.919M
104.49%
8.976M
38.45%
9.588M
30.66%
9.486M
19.52%
9.996M
12.08%
EBIT
Q2Q % growth
-3.817M
49.65%
-3.001M
39.43%
-2.66M
52.68%
-2.015M
99.03%
-2.244M
41.20%
-1.632M
45.61%
-1.734M
34.82%
-1.224M
39.24%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SRTA Yearly Revenue VS EstimatesSRTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
SRTA Yearly EPS VS EstimatesSRTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

STRATA CRITICAL MEDICAL INC / SRTA Forecast FAQ

What is the average price target for STRATA CRITICAL MEDICAL INC (SRTA) stock?

10 analysts have analysed SRTA and the average price target is 8.99 USD. This implies a price increase of 79.77% is expected in the next year compared to the current price of 5.

When does STRATA CRITICAL MEDICAL INC (SRTA) report earnings?

STRATA CRITICAL MEDICAL INC (SRTA) will report earnings on 2026-05-11.

What are the consensus estimates for STRATA CRITICAL MEDICAL INC (SRTA) next earnings?

The consensus EPS estimate for the next earnings of STRATA CRITICAL MEDICAL INC (SRTA) is -0.04 USD and the consensus revenue estimate is 64.95M USD.

What is the number of analysts for SRTA stock?

The number of analysts covering STRATA CRITICAL MEDICAL INC (SRTA) is 10.